+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Molecular Diagnostics Market Share & Global Forecast, By Application, Technology, End User, Regions, Companies

  • ID: 4912089
  • Report
  • January 2020
  • Region: Global
  • 170 Pages
  • Renub Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now
Global Molecular Diagnostics Market is Likely to Surpass US$ 22.5 Billion by the End of Year 2025

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMérieux’s Inc
  • Myriad Genetics
  • Qiagen
  • Roche Diagnostics
  • MORE

Increasing prevalence of Infectious diseases such as Influenza, HPV, Hepatitis, HIV and Tuberculosis despite rise in sanitation practices globally. In the past, antimicrobials medicines were used to fight powerful infectious disease but slowly in today's time antimicrobial agent is not able to give the desired results because the problem of drug resistant occurs in many people across the world.

Nowadays, a new diagnostic procedure is being followed to fight infectious disease like molecular diagnostic test is very effective which is quite fast and precise. The number of cancer patients is increasing very fast, so it is believed that in the coming time the molecular diagnostic test market will be growing at rapid pace. Global Molecular Diagnostics Market is likely to surpass US$ 22.5 Billion by the end of year 2025.
 
There are various reasons that will propel the market growth in forecast year; rising incidence rate of infectious disease, increasing incidence rate of cancer of all type, increasing people awareness regarding molecular diagnostic, rapid technological growth, widely acceptance of personalized medicine, rising healthcare infrastructure, increasing healthcare per capita expenditure across the developed and developing nation, accuracy of diagnosis, growing population of cardiovascular and neurological disorder etc. In addition, increasing prevalence of genetic disorder will further boost the market in forecast period of time.

The report titled “Molecular Diagnostics Market Share & Forecast, By Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others), By Technology (PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others), By End User (Hospitals & Academic Laboratories, Clinics and Commercial Laboratories, Others), By Regions [United States, Europe (Expect Russia), India, China, Japan, Brazil, South Korea, Mexico, Russia and ROW], Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others)” provides a complete analysis of Molecular Diagnostics Market.

Market Insight by Application
The report provides comprehensive analysis of molecular diagnostic test market by application into ten parts: Infectious Diseases, Genetic Testing, Blood Screening, Oncology, HLA (Tissue Typing), Microbiology, Neurological Diseases, Pharmacogenomics, Cardiovascular Diseases, and Others. This report also provides key opportunities market and specific factors are given by each application market.
 
Market Insight by Technology
Here the market is fragmented into six parts; PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others. Besides, many factors are analyzed that influence the growth, challenges and opportunities of market in technological context.

Market Insight by End User
The report provides complete insight of market by End User segments: Hospitals & Academic Laboratories, Clinics & Commercial Laboratories and Others. According to the publisher, Hospitals & Academic Laboratories will hold the largest market in global molecular diagnostic test market in forecast period of time.

Market Insight by Regions
This report covers the complete regional profile by 10 geographical market; United States, Europe, India, China, Japan, Brazil, South Korea, Mexico, Russia and Rest of World (ROW).

By Application

  • Infectious Diseases
  • Blood Screening
  • Oncology
  • Genetic Testing
  • HLA (Tissue Typing)
  • Microbiology
  • Cardiovascular Diseases
  • Neurological Diseases
  • Pharmacogenomics
  • Others

By Technology

  • PCR
  • Transcription-Mediated Amplification (TMA)
  • Hybridiazation (In-situ Hybridiazation & FISH)
  • DNA Sequencing & NGS
  • Microarray
  • Others

By End User

  • Hospitals & Academic Laboratories
  • Clinics & Commercial Laboratories
  • Others

By Regions

  • United States
  • Europe (Expect Russia)
  • India
  • China
  • Japan
  • Brazil
  • South Korea
  • Mexico
  • Russia
  • Rest of World
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMérieux’s Inc
  • Myriad Genetics
  • Qiagen
  • Roche Diagnostics
  • MORE

1. Executive Summary

2. Global Molecular Diagnostic Market

3. Market Share - Global Molecular Diagnostics
3.1 By Application
3.2 By Technology
3.3 By Countries
3.4 By Companies

4. Application - Molecular Diagnostics Market
4.1 Infectious Diseases
4.1.1 Hospital Acquired Infections (HAI)
4.1.2 HIV / HCV Testing
4.1.3 STD Testing
4.1.4 HPV Testing
4.2 Blood Screening
4.3 Oncology / Cancer
4.3.1 Breast
4.3.2 Colorectal
4.3.3 Prostate
4.3.4 Others
4.4 Genetic Testing
4.5 HLA (Tissue Typing)
4.6 Microbiology
4.7 Cardiovascular Diseases
4.8 Neurological Diseases
4.9 Pharmacogenomics
4.10 Others

5. Technology - Molecular Diagnostics Market
5.1 PCR
5.2 Transcription-Mediated Amplification (TMA)
5.3 Hybridiazation (In-situ Hybridiazation & FISH)
5.4 DNA Sequencing & NGS
5.5 Microarray
5.6 Others

6. Region - Molecular Diagnostics Market
6.1 United States
6.2 Europe
6.3 India
6.4 China
6.5 Japan
6.6 Brazil
6.7 South Korea
6.8 Mexico
6.9 Russia
6.10 Rest of World (ROW)

7. End Users - Molecular Diagnostics Market
7.1 Hospitals & Academic Laboratories
7.2 Clinics and Commercial Laboratories
7.3 Others

8. Roche Diagnostics - Company Analysis
8.1 Merger & Acquisitions
8.2 Sales Analysis

9. Abbott Laboratories - Company Analysis
9.1 Merger & Acquisitions
9.2 Sales Analysis

10. Myriad Genetics - Company Analysis
10.1 Merger & Acquisitions
10.2 Sales Analysis

11. Qiagen - Company Analysis
11.1 Merger & Acquisitions
11.2 Sales Analysis

12. BioMérieux’s Inc - Company Analysis
12.1 Merger & Acquisitions
12.2 Sales Analysis

13. Market Drivers
13.1 Various Developments in the Molecular Diagnostics Landscape
13.2 Integral to Traditional Labs
13.3 Improved Assay / Test Efficiencies
13.4 Targeting Antibiotic Resistance
13.5 Next Generation Ultrasensitive Molecular Diagnostics
13.6 Increasing Investment in Genomics & Proteomics Research
13.7 Technological Advances in Molecular Diagnostics
13.8 Increasing Acceptance of the Personalized Medicine
13.9 Growing Molecular Diagnostics for Food Safety

14. Challenges
14.1 Dearth of Trained Professionals
14.2 Regulatory Issues
14.3 Various Factors Slowing Growth of Molecular Diagnostics
14.4 Reimbursement Capabilities
14.5 Quality Checkpoints, Awareness & Acceptance

List of Figures:

Figure 2-1: Global- Molecular Diagnostics Market (Million US$), 2011 - 2019
Figure 2-2: Global - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
Figure 3-1: Global- Molecular Diagnostics Market Share by Application (Percent), 2011 - 2019
Figure 3-2: Global- Forecast for Molecular Diagnostics Market Share by Application (Percent)
Figure 3-3: Global- Molecular Diagnostics Market Share by Technology (Percent), 2011 - 2019
Figure 3-4: Global- Forecast for Molecular Diagnostics Market Share by Technology (Percent)
Figure 3-5: Global- Molecular Diagnostics Market Share by Countries (Percent), 2011 - 2019
Figure 3-6: Global- Forecast for Molecular Diagnostics Market Share by Countries (Percent)
Figure 4-1: Global- Molecular Diagnostics Market by Infectious Diseases (Million US$)
Figure 4-2: Global- Forecast for Molecular Diagnostics Market by Infectious Diseases (Million US$), 2020 - 2025
Figure 4-3: Global- Molecular Diagnostics Market by Hospital Acquired Infection (Million US$)
Figure 4-4: Global- Forecast for Molecular Diagnostics Market by Hospital Acquired Infection
Figure 4-5: Global- Molecular Diagnostics Market by HIV/HCV Testing (Million US$), 2011 - 2019
Figure 4-6: Global- Forecast for Molecular Diagnostics Market by HIV/HCV Testing (Million US$)
Figure 4-7: Global- Molecular Diagnostics Market by STD Testing (Million US$), 2011- 2019
Figure 4-8: Global- Forecast for Molecular Diagnostics Market by STD Testing (Million US$)
Figure 4-9: Global- Molecular Diagnostics Market by HPV Testing (Million US$), 2011 - 2019
Figure 4-10: Global- Forecast for Molecular Diagnostics Market by HPV Testing (Million US$)
Figure 4-11: Global- Molecular Diagnostics Market by Blood Screening (Million US$), 2010 - 2019
Figure 4-12: Global- Forecast for Molecular Diagnostics Market by Blood Screening (Million US$), 2020 - 2025
Figure 4-13: Global- Molecular Diagnostics Market by Oncology (Million US$), 2010 - 2019
Figure 4-14: Global- Forecast for Molecular Diagnostics Market by Oncology (Million US$)
Figure 4-15: Global- Molecular Diagnostics Market by Breast (Million US$), 2010 - 2019
Figure 4-16: Global- Forecast for Molecular Diagnostics Market by Breast (Million US$), 2020 - 2025
Figure 4-17: Global- Molecular Diagnostics Market by Colorectal (Million US$), 2010 - 2019
Figure 4-18: Global- Forecast for Molecular Diagnostics Market by Colorectal (Million US$)
Figure 4-19: Global- Molecular Diagnostics Market by Prostate (Million US$), 2010 - 2019
Figure 4-20: Global- Forecast for Molecular Diagnostics Market by Prostate (Million US$), 2020 - 2025
Figure 4-21: Global- Molecular Diagnostics Market by Others (Million US$), 2010 - 2019
Figure 4-22: Global- Forecast for Molecular Diagnostics Market by Others (Million US$), 2020 - 2025
Figure 4-23: Global- Molecular Diagnostics Market by Genetic Testing (Million US$), 2010 - 2018
Figure 4-24: Global- Forecast for Molecular Diagnostics Market by Genetic Testing (Million US$)
Figure 4-25: Global- Molecular Diagnostics Market by HLA (Tissue Typing) (Million US$), 2011 - 2019
Figure 4-26: Global- Forecast for Molecular Diagnostics Market by HLA (Tissue Typing) (Million US$), 2020 - 2025
Figure 4-27: Global- Molecular Diagnostics Market by Microbiology (Million US$), 2011 - 2019
Figure 4-28: Global- Forecast for Molecular Diagnostics Market by Microbiology (Million US$)
Figure 4-29: Global- Forecast for Molecular Diagnostics Market by Cardiovascular Diseases (Million US$), 2011 - 2019
Figure 4-30: Global- Forecast for Molecular Diagnostics Market by Cardiovascular Diseases (Million US$), 2020 - 2025
Figure 4-31: Global- Molecular Diagnostics Market by Neurological Diseases (Million US$), 2011 - 2019
Figure 4-32: Global- Forecast for Molecular Diagnostics Market by Neurological Diseases (Million US$), 2020 - 2025
Figure 4-33: Global- Molecular Diagnostics Market by Pharmacogenomics (Million US$), 2011 - 2019
Figure 4-34: Global- Forecast for Molecular Diagnostics Market by Pharmacogenomics (Million US$), 2020 - 2025
Figure 4-35: Global- Molecular Diagnostics Market by Others (Million US$), 2011 - 2019
Figure 4-36: Global- Forecast for Molecular Diagnostics Market by Others (Million US$), 2020 - 2025
Figure 5-1: Global- Molecular Diagnostics Market by PCR (Million US$), 2011 - 2019
Figure 5-2: Global- Forecast for Molecular Diagnostics Market by PCR (Million US$), 2020 - 2025
Figure 5-3: Global- Molecular Diagnostics Market by TMA (Million US$), 2011 - 2019
Figure 5-4: Global- Forecast for Molecular Diagnostics Market by TMA (Million US$), 2020 - 2025
Figure 5-5: Global- Molecular Diagnostics Market by Hybridiazation (Million US$), 2011 - 2019
Figure 5-6: Global- Forecast for Molecular Diagnostics Market by Hybridiazation (Million US$)
Figure 5-7: Global- Molecular Diagnostics Market by DNA Sequencing & NGS (Million US$)
Figure 5-8: Global- Forecast for Molecular Diagnostics Market by DNA Sequencing & NGS (Million US$), 2020 - 2025
Figure 5-9: Global- Molecular Diagnostics Market by Microarray (Million US$), 2011 - 2019
Figure 5-10: Global- Forecast for Molecular Diagnostics Market by Microarray (Million US$), 2020 - 2025
Figure 5-11: Global- Molecular Diagnostics Market by Others (Million US$), 2011 - 2019
Figure 5-12: Global- Forecast for Molecular Diagnostics Market by Others (Million US$), 2020 - 2025
Figure 6-1: United States - Molecular Diagnostics Market (Million US$), 2011 - 2019
Figure 6-2: United States - Forecast for Molecular Diagnostics Market (Million US$), 2019 - 2028
Figure 6-3: Europe - Molecular Diagnostics Market (Million US$), 2011 - 2019
Figure 6-4: Europe - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
Figure 6-5: India -Molecular Diagnostics Market (Million US$), 2011 - 2019
Figure 6-6: India - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
Figure 6-7: China - Molecular Diagnostics Market (Million US$), 2011 - 2019
Figure 6-8: China - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
Figure 6-9: Japan -Molecular Diagnostics Market (Million US$), 2011 - 2019
Figure 6-10: Japan - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
Figure 6-11: Brazil -Molecular Diagnostics Market (Million US$), 2011 - 2020
Figure 6-12: Brazil - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
Figure 6-13: South Korea -Molecular Diagnostics Market (Million US$), 2011 - 2019
Figure 6-14: South Korea - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
Figure 6-15: Mexico -Molecular Diagnostics Market (Million US$), 2011 - 2019
Figure 6-16: Mexico - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
Figure 6-17: Russia -Molecular Diagnostics Market (Million US$), 2011 - 2019
Figure 6-18: Russia - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
Figure 6-19: ROW -Molecular Diagnostics Market (Million US$), 2011 - 2019
Figure 6-20: ROW - Forecast for Molecular Diagnostics Market (Million US$), 2020 - 2025
Figure 7-1: Global - Molecular Diagnostics Market by Hospitals & Academic Laboratories (Million US$), 2011 - 2019
Figure 7-2: Global - Forecast for Molecular Diagnostics Market by Hospitals & Academic Laboratories (Million US$), 2020 - 2025
Figure 7-3: Global - Molecular Diagnostics Market by Clinics and Commercial Laboratories (Million US$), 2011 - 2019
Figure 7-4: Global - Forecast for Molecular Diagnostics Market by Clinics and Commercial Laboratories (Million US$), 2019 - 2025
Figure 7-5: Global - Molecular Diagnostics Market by Others (Million US$), 2011 - 2019
Figure 7-6: Global - Forecast for Molecular Diagnostics Market by Others (Million US$), 2020 - 2025
Figure 8-1: Roche - Molecular Diagnostics Sales (Million US$), 2011 - 2019
Figure 8-2: Roche - Forecast for Molecular Diagnostics Sales (Million US$), 2020 - 2025
Figure 9-1: Abbott Laboratories- Molecular Diagnostics Sales (Million US$), 2011 - 2019
Figure 9-2: Abbott Laboratories - Forecast for Molecular Diagnostics Sales (Million US$), 2020 - 2025
Figure 10-1: Myriad Genetics -Molecular Diagnostics Sales (Million US$), 2011 - 2019
Figure 10-2: Myriad Genetics - Forecast for Molecular Diagnostics Sales (Million US$), 2020 - 2025
Figure 11-1: Qiagen -Molecular Diagnostics Sales (Million US$), 2011 - 2019
Figure 11-2: Qiagen - Forecast for Molecular Diagnostics Sales (Million US$), 2019 - 2025

Note: Product cover images may vary from those shown
3 of 4
  • Roche Diagnostics
  • Abbott Laboratories
  • Myriad Genetics
  • Qiagen
  • BioMérieux’s Inc
Note: Product cover images may vary from those shown
4 of 4

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll